Skip to content

Ingevity NGVT Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

PPG Industries logo
PPG IndustriesPPG
Westlake logo
WestlakeWLK
NewMarket logo
NewMarketNEU
Minerals Technologies logo
Minerals TechnologiesMTX
Celanese Corporation logo
Celanese CorporationCE
Entegris logo
EntegrisENTG

Other financials

Income statement

See full
Revenue$258.0M+4.1%
Gross profit$116.4M+4.0%
Net income$59.8M+192%
EPS (diluted)$1.66+196%

Balance sheet

See full
Cash & equivalents$95.4M+5.0%
Total debt$1.4B-9.0%
Total equity$38.9M-83.4%
Total assets$1.7B-19.7%

Cash flow

See full
Operating cash flow-$2.0M-108%
CapEx$10.3M+3.0%
Free cash flow-$12.3M-180%

Valuation

See full
Market cap$2.53B+73.9%
Enterprise value$3.8B+32.4%
P/S2.1×+0.9×

Profitability

See full
Gross margin39.3%+1.5pp
Net margin-10.6%-4.1pp
FCF margin20.3%+12.6pp

Returns & leverage

See full
Return on equity-93.5%+1.2pp
Debt / equity35.1×+28.7×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Ingevity in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Ingevity’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingevity's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ingevity's common stock, shares authorized (in shares)?
Ingevity (NGVT) reported common stock, shares authorized (in shares) of $300M in Q1 2026.
How has Ingevity's common stock, shares authorized (in shares) changed year-over-year?
Ingevity's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $300M to $300M.
What is the long-term trend for Ingevity's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Ingevity's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $300M to $300M.